Cairo – Mubasher: October Pharma achieved a 65% year-on-year (YoY) increase in its net profits, logging EGP 100.32 million in the first nine months of 2021, compared to EGP 60.67 million. 

The revenues levelled up to EGP 489.07 million in the January-September period of 2021 from EGP 379.2 million in the prior-year period, the company said in a bourse disclosure on Tuesday. 

During the first quarter (Q1) of 2021, the company posted net profits of EGP 40.59 million, up from EGP 8.08 million in Q1-20.